Johnson & Johnson Cash on Hand 2012-2026 | JNJ

Johnson & Johnson cash on hand for the quarter ending March 31, 2026 was $20.102B, a 18.02% decline year-over-year.

  • Johnson & Johnson cash on hand for 2025 was $20.102B, a 18.02% decline from 2024.
  • Johnson & Johnson cash on hand for 2024 was $24.522B, a 6.96% increase from 2023.
  • Johnson & Johnson cash on hand for 2023 was $22.927B, a 2.9% increase from 2022.

Johnson & Johnson Cash on Hand 2012-2026 | JNJ

  • Johnson & Johnson cash on hand for 2025 was $20.102B, a 18.02% decline from 2024.
  • Johnson & Johnson cash on hand for 2024 was $24.522B, a 6.96% increase from 2023.
  • Johnson & Johnson cash on hand for 2023 was $22.927B, a 2.9% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B